GlassScriptPhysician profile
Lisa C Wittmann
NPI 1619927662
$1,854.92
in general payments reported to CMS, 2019-2025
22 companies · $553 in 2025
The $553 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.48 · 2021: $64.28 · 2022: $260 · 2023: $314 · 2024: $600 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $461.06 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $356.19 | 2023-2025 | Qelbree, Qelbree |
| Pfizer INC. | $140.97 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $108.77 | 2025 | Jornay Pm |
| Sobi, INC | $107.72 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $93.33 | 2022-2025 | Gardasil 9, Gardasil, Capvaxive |
| Exact Sciences Corporation | $79.67 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $68.85 | 2021-2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $67.22 | 2024-2025 | |
| Sanofi Pasteur INC. | $50.21 | 2021-2022 | |
| Heartflow, INC. | $47.82 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.51 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.90 | 2022-2024 | Xifaxan |
| Organogenesis INC. | $41.67 | 2025 | Puraply Wound Matrix |
| Glaxosmithkline, LLC. | $25.63 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $22.59 | 2025 | Ycanth |
| Abbott Laboratories | $19.51 | 2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $17.19 | 2025 | Voquezna |
| Relievant Medsystems, INC. | $17.10 | 2022 | |
| Cranial Technologies, INC | $15.84 | 2022 | |
| Biogen, INC. | $13.85 | 2025 | Skyclarys |
| Amgen INC. | $13.32 | 2024 | Repatha, Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Wittmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.